Source: Annual Congress 2003 - Current issues on wheezing in infancy
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Katier, C. S. Uiterwaal, J. L. Kimpen, T. Verheij, C. K. Van der Ent (Utrecht, The Netherlands). The wheezing illnesses study Leidsche Rijn (WHISTLER). Eur Respir J 2003; 22: Suppl. 45, 2512

Member's Comments

No comment yet.

Related content which might interest you: Changes in respiratory health and allergies in children and adolescents in Antwerp (Belgium) from 1996 to 2002 (ISAAC) Source: Eur Respir J 2004; 24: Suppl. 48, 439s Year: 2004 “Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results”. Robert Wilson, Antonio Anzueto, Marc Miravitlles, Pierre Arvis, Jeff Alder, Daniel Haverstock, Mila Trajanovic and Sanjay Sethi. Eur Respir J 2012; 40: 17–27.}, Source: Eur Respir J 2012; 40: 800 Year: 2012 COPD prevalence in Spain in 2007 (EPI-SCAN study results) Source: Annual Congress 2008 - COPD epidemiology Year: 2008 “Physical activity as a moderator for obstructive sleep apnoea and cardiometabolic risk in the EPISONO study.” Marcos Mônico-Neto, Hanna Karen Moreira Antunes, Ronaldo Vagner Thomatieli dos Santos, Vânia D'Almeida, Altay Alves Lino de Souza, Lia Rita Azeredo Bittencourt and Sergio Tufik. Eur Respir J 2018; 52: 1701972. Source: Eur Respir J, 52 (6) 1751972; 10.1183/13993003.51972-2017 Year: 2018 Hospitalisations for exacerbations of COPD, France, 1998-2007 Source: Annual Congress 2009 - Exacerbations and characteristics of COPD Year: 2009 “Community-acquired pneumonia in younger patients is an entity on its own.” Benjamin Klapdor, Santiago Ewig, Mathias W. Pletz, Gernot Rohde, Hartwig Schütte, Tom Schaberg and Tobias Welte for the CAPNETZ study group. Eur Respir J 2012; 39: 1156–1161. Source: Eur Respir J 2012; 40: 1583 Year: 2012 “ERS guidelines on the diagnosis and treatment of chronic cough in adults and children.” Alyn H. Morice, Eva Millqvist, Kristina Bieksiene, Surinder S. Birring, Peter Dicpinigaitis, Christian Domingo Ribas, Michele Hilton Boon, Ahmad Kantar, Kefang Lai, Lorcan McGarvey, David Rigau, Imran Satia, Jacky Smith, Woo-Jung Song, Thomy Tonia, Jan W.K. van den Berg, Mirjam J.G. van Manen and Angela Zacharasiewicz. Eur Respir J 2020; 55: 1901136. Source: Eur Respir J, 56 (5) 1951136; 10.1183/13993003.51136-2019 Year: 2020 “Low prevalence of fluoroquinolone resistance among patients with tuberculosis in the Philippines: results of a national survey.” Dodge R. Lim, Anna S. Dean, Mary Rosary Taguinod-Santiago, Angeli Borbe-Reyes, Andrea Maurizio Cabibbe, Matteo Zignol, Ramon P. Basilio, Anna Marie Celina Garfin and Maria Cecilia G. Ama. Eur Respir J 2018; 51: 1702571. Source: Eur Respir J, 51 (5) 1752571; 10.1183/13993003.52571-2017 Year: 2018 “Echocardiographic abnormalities in patients with COPD at their first hospital admission.” Xavier Freixa, Karina Portillo, Carles Paré, Judith Garcia-Aymerich, Federico P. Gomez, Marta Benet, Josep Roca, Eva Farrero, Jaume Ferrer, Carlos Fernandez-Palomeque, Josep M. Antó and Joan Albert Barberà, on behalf of the PAC-COPD Study Investigators. Eur Respir J 2013; 41: 784–791. Source: Eur Respir J 2015; 46: 1533 Year: 2015 Smoking and bronchitis symptoms among Irish school children: an ISAAC protocol study, 1995-2007 Source: Annual Congress 2008 - Tobacco control and teenagers Year: 2008 Epidemiology of tuberculosis among hospitalized paediatric patients in the Maria Auxiliadora´s hospital in Lima-Peru (2004-2005) Source: Eur Respir J 2007; 30: Suppl. 51, 391s Year: 2007 “Asthma inhaler adherence determinants in adults: systematic review of observational data.” Alexandra L. Dima, Gimena Hernandez, Oriol Cunillera, Montserrat Ferrer, Marijn de Bruin and the ASTRO-LAB group. Eur Respir J 2015; 45: 994–1018. Source: Eur Respir J 2016; 47:1892 Year: 2016 “Clinical experience with antifibrotics in fibrotic hypersensitivity pneumonitis: a 3-year real-life observational study” Vasilios Tzilas, Argyris Tzouvelekis, Evangelos Bouros, Theodoros Karampitsakos, Maria Ntassiou, Eleni Avdoula, Athena Trachalaki, Katerina Antoniou, Ganesh Raghu and Demosthenes Bouros. ERJ Open Res 2020; 6: 00152-2020. Source: ERJ Open Res, 7 (1) 50152-2020; 10.1183/23120541.50152-2020 Year: 2021 “ERS and tobacco harm reduction.” Charlotta Pisinger, Elif Dagli, Filippos T. Filippidis, Linnea Hedman, Christer Janson, Stelios Loukides, Sofia Ravara, Isabel Saraiva and Jørgen Vestbo, the ERS Tobacco Control Committee, on behalf of the ERS. Eur Respir J 2019; 54: 1902009. Source: Eur Respir J, 55 (1) 1952009; 10.1183/13993003.52009-2019 Year: 2020 “Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial.” Gerard Muñoz, Javier de Gracia, Maria Buxó, Antonio Alvarez and Montserrat Vendrell. Eur Respir J 2018; 51: 1701926. Source: Eur Respir J, 51 (4) 1751926; 10.1183/13993003.51926-2017 Year: 2018 Asthma, wheeze, hay fever and eczema among Irish school children: an ISAAC protocol prevalence study, 1995-2007 Source: Annual Congress 2009 - Epidemiology of atopy and asthma Year: 2009 “Still Fighting for Breath: a patient survey of the challenges and impact of severe asthma” Paraskevi Katsaounou, Mikaela Odemyr, Otto Spranger, Michael E. Hyland, Claus Kroegel, Lorena Garcia Conde, Robin Gore, Francesco Menzella, Christian Domingo Ribas, Mario Morais-Almeida, Matthias Gasser and Ismail Kasujee. ERJ Open Res 2018; 4: 00076-2018. Source: ERJ Open Res, 5 (1) 00076-2018-AUT; 10.1183/23120541.50076-2018 Year: 2019 “Prolonged shedding of rhinovirus and re-infection in adults with respiratory tract illness.” Kalina T. Zlateva, Jutte J.C. de Vries, Frank E.J. Coenjaerts, Anton M. van Loon, Theo Verheij, Paul Little, Christopher C. Butler, Herman Goossens, Margareta Ieven and Eric C.J. Claas on behalf of the GRACE Study Group. Eur Respir J 2014; 44: 169–177. Source: Eur Respir J 2014; 44: 556 Year: 2014 Trends in hospital admissions for wheezing illness among children in Sweden 1987-1999 Source: Eur Respir J 2002; 20: Suppl. 38, 390s Year: 2002 Retraction notice for: “Characteristics and risk factors for COVID-19 diagnosis and adverse outcomes in Mexico: an analysis of 89,756 laboratory-confirmed COVID-19 cases.” Theodoros V. Giannouchos, Roberto A. Sussman, José M. Mier, Konstantinos Poulas and Konstantinos Farsalinos. Eur Respir J 2020; in press. Source: Eur Respir J, 57 (3) 2002144; 10.1183/13993003.02144-2020 Year: 2021